An important paper on homeopathy and cancer appeared in the February 2010 issue of the International Journal of Oncology. Scientists at the University of Texas M.D. Anderson Cancer Center (MDA), led by Dr. Moshe Frenkel, have demonstrated the beneficial effects of homeopathic medicines on breast cancer cells. Four ultra-dilute remedies were used in the study - Carcinosin, Phytolacca, Conium and Thuja.
According to the researchers: "The remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis".
According to the researchers: "The remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis".
Dr. Frenkel has stated: "This is the first scientific study that investigated the effect of homeopathic remedies on breast cancer cells", and referred to an "exciting possibility" of the "therapeutic opportunity for preferentially eliminating breast cancer cells with minimal damage to the surrounding normal mammary tissue by using homeopathic remedies."
For homeopathy, under attack from pro-ConMed denialists as they are, the paper is important as it shows that ultra-dilute products do have significant physical effects even when the dilution is outside Avogadro's Limit - that is, when none of the original substance is present. Further it shows that the homeopathic remedies used in the study (and much used in the treatment of people with cancer) can have an effect on cancer cells, equivalent to that of the major chemo-drug used as a control, Paclitaxel (Taxol).
The main difference, of course, is the the homeopathic remedy will have no adverse effect on normal cells.
For further details, see the following:
For further details, see the following:
